Table 3

Physical parameters values of PS-DHA continuers* at baseline and following 30 weeks of treatment

Variable

Baseline (mean ± SD)

30 weeks (mean ± SD)

P value

Resting systolic BP (mm Hg)

127.2 ± 13.5

126.3 ± 14.0

0.594

Male

125.7 ± 13.7

126.5 ± 14.3

0.716

Female

128.6 ± 13.4

126.0 ± 14.0

0.366

Resting diastolic BP (mm Hg)

73.8 ± 9.4

70.7 ± 9.8

0.006

Male

73.8 ± 9.7

71.6 ± 8.7

0.195

Female

73.8 ± 9.3

69.9 ± 10.7

0.010

Resting pulse (beats/minute)

69.4 ± 10.0

70.6 ± 11.9

0.368

Male

69.3 ± 11.6

71.1 ± 13.4

0.412

Female

69.5 ± 8.5

70.1 ± 10.6

0.687

Weight (kg)

70.0 ± 11.2

70.7 ± 11.4

0.015

Male

77.1 ± 9.6

77.7 ± 9.8

0.067

Female

63.7 ± 8.5

64.3 ± 8.8

0.104

* include 29 males and 32 females

P value based on two-sided t test for dependent samples

Vakhapova et al. BMC Neurology 2011 11:79   doi:10.1186/1471-2377-11-79